| __timestamp | Apellis Pharmaceuticals, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 8393000000 |
| Thursday, January 1, 2015 | 13730311 | 7690000000 |
| Friday, January 1, 2016 | 22978599 | 7872000000 |
| Sunday, January 1, 2017 | 40303878 | 7657000000 |
| Monday, January 1, 2018 | 105285576 | 8006000000 |
| Tuesday, January 1, 2019 | 220968770 | 8650000000 |
| Wednesday, January 1, 2020 | 299921000 | 9405000000 |
| Friday, January 1, 2021 | 420869000 | 13829000000 |
| Saturday, January 1, 2022 | 387236000 | 11428000000 |
| Sunday, January 1, 2023 | 354387000 | 10679000000 |
| Monday, January 1, 2024 | 10930000000 |
Data in motion
In the ever-evolving landscape of pharmaceutical research, the investment in Research and Development (R&D) is a critical indicator of a company's commitment to innovation. Over the past decade, Pfizer Inc. and Apellis Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D expenditures.
From 2014 to 2023, Pfizer consistently allocated substantial resources to R&D, with an average annual investment of approximately $9.4 billion. This represents a steadfast commitment to innovation, with a peak in 2021, where R&D expenses soared by nearly 50% compared to 2014. In contrast, Apellis Pharmaceuticals, a smaller player, showed a remarkable growth trajectory, increasing its R&D spending by over 4000% during the same period.
This data underscores the diverse approaches within the pharmaceutical industry, where both giants and emerging companies play pivotal roles in advancing medical science.
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Pfizer Inc. and Rhythm Pharmaceuticals, Inc. Allocate Funds
Pfizer Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Viridian Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.